Functional exploration of copy number alterations in a Drosophila model of triple negative breast cancer
Accounting for 10-20% of breast cancer cases, TNBC is associated with a disproportionate number of breast cancer deaths. One challenge in studying TNBC is its genomic profile: outside of TP53 loss, most cases are characterized by copy number alterations (CNAs), making modeling the disease in whole a...
Saved in:
Published in | Disease models & mechanisms Vol. 17; no. 7 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
England
The Company of Biologists Ltd
01.07.2024
The Company of Biologists |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Accounting for 10-20% of breast cancer cases, TNBC is associated with a disproportionate number of breast cancer deaths. One challenge in studying TNBC is its genomic profile: outside of TP53 loss, most cases are characterized by copy number alterations (CNAs), making modeling the disease in whole animals challenging. We computationally analyzed 186 previously identified CNA regions in breast cancer to rank genes within each region by likelihood of acting as a tumor driver. We then used a Drosophila p53-Myc TNBC model to identify 48 genes as functional drivers. To demonstrate the utility of this functional database, we established six 3-hit models; altering candidates led to increased aspects of transformation as well as resistance to the chemotherapeutic drug fluorouracil. Our work provides a functional database of CNA-associated TNBC drivers, and a template for an integrated computational/whole animal approach to identify functional drivers of transformation and drug resistance within CNAs for other tumor types. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 Present address: Department of Medicine, Divisions of Hematology and Oncology; Washington University in St. Louis, MO 63110, USA Competing interests Present address: School of Cancer Sciences and Wolfson Wohl Cancer Research Centre, University of Glasgow, Glasgow G61 1BD, UK. The authors declare no competing or financial interests. Handling Editor: Elaine R. Mardis |
ISSN: | 1754-8403 1754-8411 1754-8411 |
DOI: | 10.1242/dmm.050191 |